Permanent Peoples' Tribunal accuses biotech giants Monsanto, Dow, Bayer, Syngenta, DuPont and BASF of promoting dangerous pesticides including endosulfan, paraquat and neonicotinoids
The world's major agrochemical companies, Monsanto, Dow, Bayer, Syngenta, DuPont and BASF, will face a public tribunal in early December accused of systematic human rights violations.
They are accused of violating more than 20 instruments of international human rights law through promoting reliance on the sale and use of dangerous and unsafe pesticides including endosulfan, paraquat and neonicotinoids.
The Permanent Peoples' Tribunal (PPT), an international opinion tribunal created in 1979, will hear expert testimony from scientists, medical doctors and lawyers to prove the charges. Victims who have been injured by these products - from farmers, farmworkers, mothers and consumers from around the world - will also testify to the causes and nature of their injuries.
The cases will be heard over a four-day trial in Bangalore, India beginning December 3. While the Tribunal has no legal weight, and cannot force sanctions on companies, it aims to expose and raise awareness of large-scale human rights violations.
Pesticides Action Network (PAN) International, a global network comprised of 600 organisations in 90 countries, has spent years collecting information to bring about the indictments and is seeking justice for more than 25 specific cases - such as Silvino Talavera, an 11-year-old from Paraguay who died days after breathing in a cloud of Monsanto's RoundUp herbicide sprayed by a crop duster. The trial will also hear evidence of the link between pesticide use and a decline in bees.
The corporations, known as the 'Big 6' control 74 per cent of the global pesticide market, as well as dominating the global seed market.
Bayer reject the allegations saying they are a 'wholesale distortion of the role of pesticides in our society.' Monsanto, Syngenta and Dow, after being contacted by the Ecologist, were unavailable for comment.
No comments:
Post a Comment